Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4+CD25+-dependent mechanism and by shifting cytokine production to favor a Th1 responseBraden Waters, David Lillicrap, Mohammad Qadura et al.|Blood|2008Cited by 82
Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A miceMohammad Qadura, David Lillicrap, Maha Othman et al.|Blood|2009Cited by 63
Reduction of the immune response to factor VIII mediated through tolerogenic factor VIII presentation by immature dendritic cellsMohammad Qadura, David Lillicrap, Maha Othman et al.|Journal of Thrombosis and Haemostasis|2008Cited by 42
Immunoglobulin isotypes and functional anti-FVIII antibodies in response to FVIII treatment in Balb/c and C57BL/6 haemophilia A miceMohammad Qadura, David Lillicrap, Braden Waters et al.|Haemophilia|2010Cited by 36
The challenge of genetically unresolved haemophilia A patients: Interest of the combination of whole <i>F8</i> gene sequencing and functional assaysFanny Lassalle, David Lillicrap, Yohann Jourdy et al.|Haemophilia|2020Cited by 15